Fucoidan Extracted From New Zealand Undaria Pinnatifida – Physicochemical Comparison Against Five Other Fucoidans: Unique Low Molecular Weight Fraction Bioactivity in Breast Cancer Cell Lines
Loading...
Files
Size: 4.5 MB, File format: Adobe PDF
Date
Authors
Lu, Jun
Hassouna, Amira
Shi, Keyu Kally
Chen, Shuping
Wang, Junqiao
Hassouna, Amira
White, Loretta Nicole
Merien, Fabrice
Xie, Mingyong
Kong, Qingjun
Supervisor
Item type
Degree name
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI AG
Abstract
Fucoidan, the complex fucose-containing sulphated polysaccharide varies considerably in structure, composition, and bioactivity, depending on the source, species, seasonality, and extraction method. In this study, we examined five fucoidans extracted from the same seaweed species Undaria pinnatifida but from different geological locations, and compared them to the laboratory-grade fucoidan from Sigma (S). The five products differed in molecular composition. The amount of over 2 kDa low molecular weight fraction (LMWF) of the New Zealand crude fucoidan (S1) was larger than that of S, and this fraction was unique, compared to the other four fucoidans. The difference of molecular compositions between S and S1 explained our previous observation that S1 exhibited different anticancer profile in some cancer cell lines, compared with S. Since we observed this unique LMWF, we compared the cytotoxic effects of a LMWF and a high molecular weight fucoidan (HMWF) in two breast cancer cell lines—MCF-7 and MDA-MB-231. Results indicated that the molecular weight is a critical factor in determining the anti-cancer potential of fucoidan, from the New Zealand U. pinnatifida, as the LMWF exhibited a dose-dependent inhibition on the proliferation of breast cancer cells, significantly better than the HMWF, in both cell lines. A time-dependent inhibition was only observed in the MCF-7. Induction of caspase-dependent apoptosis was observed in the MDA-MB-231 cells, through the intrinsic apoptosis pathway alone, or with the extrinsic pathway. LMWF stimulated a dose-dependent NOS activation in the MDA-MB-231 cells. In conclusion, the fucoidan extracted from the New Zealand U. pinnatifida contains a unique LMWF, which could effectively inhibit the growth of breast cancer cell lines. Therefore, the LMWF from New Zealand U. pinnatifida could be used as a supplement cancer treatment.
Description
Keywords
Fucoidan, Chemical composition, Molecular weight, Breast cancer cell lines, Nutraceutical
Source
Marine Drugs, 16(12), 461. doi:10.3390/md16120461
Publisher's version
Rights statement
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This is an open access article.
Permanent link
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Creative Commons Attribution (CC BY) license